Cooper Net Change in Short-term Investments 2010-2025 | COO
Cooper annual/quarterly net change in short-term investments history and growth rate from 2010 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
- Cooper net change in short-term investments for the quarter ending April 30, 2025 was $0M, a 0% increase year-over-year.
- Cooper net change in short-term investments for the twelve months ending April 30, 2025 was $0M, a 0% increase year-over-year.
- Cooper annual net change in short-term investments for 2024 was $0B, a 0% decline from 2023.
- Cooper annual net change in short-term investments for 2023 was $0B, a 0% decline from 2022.
- Cooper annual net change in short-term investments for 2022 was $0B, a 0% decline from 2021.
Cooper Annual Net Change in Short-term Investments (Millions of US $) |
2024 |
$N/A |
2023 |
$N/A |
2022 |
$N/A |
2021 |
$N/A |
2020 |
$N/A |
2019 |
$N/A |
2018 |
$N/A |
2017 |
$N/A |
2016 |
$N/A |
2015 |
$N/A |
2014 |
$N/A |
2013 |
$N/A |
2012 |
$N/A |
2011 |
$N/A |
2010 |
$N/A |
2009 |
$N/A |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$15.043B |
$3.895B |
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|